(Q36405369)

English

The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1. (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

cholangiocarcinoma

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

metastatic carcinoma

1 reference

based on heuristic

inferred from title

author name string

Nehal A Radwan

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Naglaa S Ahmed

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

publication date

30 October 2012

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Diagnostic Pathology

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

149

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

30 October 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

30 September 2017

Expression of hepatocyte markers in mass-forming peripheral and periductal-infiltrating hilar intrahepatic cholangiocarcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

30 September 2017

Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

30 September 2017

Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

30 September 2017

Hepatocellular carcinoma: focus on different aspects of management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

30 September 2017

Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

30 September 2017

Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: a historical prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

30 September 2017

Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

30 September 2017

Hepatitis C virus targets over-expression of arginase I in hepatocarcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

30 September 2017

Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

30 September 2017

Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

30 September 2017

HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

30 September 2017

The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from nonhepatic tumors: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

30 September 2017

Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

30 September 2017

Unusual reticulin staining pattern in well-differentiated hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

28 June 2018

Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

21 September 2018

Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

21 September 2018

Immunohistochemical study of arginase 1 and 2 in various tissues of rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

21 September 2018

Dicer is required for proper liver zonation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

21 September 2018

Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

21 September 2018

Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

21 September 2018

Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3500209

21 September 2018

Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of glypican 3 in ovarian and extragonadal germ cell tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatobiliary pathology

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical localisation of arginase in human liver using monoclonal antibodies against human liver arginase

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1746-1596-7-149

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36405369&oldid=2198841904"